Previous 10 | Next 10 |
2023-08-30 08:54:37 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips This year has not been kind to biotech stocks , as the sector’s most popular ETF, the iShares Biotechnology ETF (NASDAQ: IBB ), has fallen about 3% so far in 2023. In...
2023-08-28 06:48:26 ET More on Elite Elite Pharmaceuticals, Inc. ( OTCQB:ELTP ) Q1 2024 Earnings Call Transcript Elite Pharmaceuticals, Inc. ( OTCQB:ELTP ) Q4 2023 Earnings Call Transcript Elite Pharmaceuticals enters exclusive distribution agreement with Pra...
2023-08-17 03:12:23 ET Summary William von Mueffling's 13F portfolio value increased by 17% to $14.31B in Q2 2023. The top five positions in the portfolio are Broadcom, S&P Global, Analog Devices, Visa, and Alphabet. New stakes include Live Nation Entertainment and Tradewe...
2023-08-03 05:15:44 ET Summary IQVIA Holdings Inc. has demonstrated impressive growth in Q2, beating earnings and revenue expectations. The company operates in multiple segments, including Technology & Analytics Solutions and Research & Development Solutions. IQVIA has...
2023-08-01 17:34:03 ET IQVIA Holdings Inc. (IQV) Q2 2023 Earnings Conference Call August 01, 2023 09:00 AM ET Company Participants Nick Childs - SVP, IR and Treasurer Ari Bousbib - Chairman and CEO Ron Bruehlman - EVP and CFO Conference Call Participants ...
2023-08-01 07:09:34 ET IQVIA press release ( NYSE: IQV ): Q2 Non-GAAP EPS of $2.43 beats by $0.06 . Revenue of $3.73B (+5.4% Y/Y) beats by $20M . The updated revenue guidance range of $15,050 million to $15,175 million represents growth of 4.4 to 5.3 percent on...
Revenue of $3,728 million grew 5.3 percent year-over-year on a reported basis and 5.5 percent at constant currency GAAP Net Income of $297 million grew 16.0 percent year-over-year Adjusted EBITDA of $864 million grew 8.0 percent year-over-year GAAP Diluted Earnings per Sha...
2023-07-31 14:34:07 ET IQVIA ( NYSE: IQV ) is scheduled to announce Q2 earnings results on Tuesday, August 1st, before market open. The consensus EPS Estimate is $2.37 (-2.9% Y/Y) and the consensus Revenue Estimate is $3.71B (+4.8% Y/Y). Over the last 2 years, IQV ha...
2023-07-28 05:20:00 ET Summary Cedar Creek Capital Management took advantage of an opportunity in the expert market by purchasing shares of Propel Media at a low price. Propel Media may potentially be acquired by IQVIA Holdings for a reported price of $700 to $800 million, which c...
2023-07-27 05:10:00 ET Summary Cedar Creek decreased by 2.5% in the second quarter, and was up 3.7% for the first half of 2023, net of fees and expenses. On the whole, as of the end of June 2023, the fund’s holdings were trading at 5.0 times our estimate of earnings for the...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...